ExLibris header image
SFX Logo
Title: AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Pépin, David yr:2015


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. "AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy." Proceedings of the National Academy of Sciences of the United States of America. 114.9. Link to SFX for this item
2. Jendzelovsky, R. "Proadifen sensitizes resistant ovarian adenocarcinoma cells to cisplatin." Toxicology Letters 243 (2016): 56-66. Link to SFX for this item
3. Topp, Monique D. "Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts." Molecular Oncology 8.3 (2014): 656-668. Link to Full Text for this item Link to SFX for this item
4. Whicker, Margaret E. "MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib." BMC cancer 16.1 (2016): 550-550. Link to Full Text for this item Link to SFX for this item
5. El Senduny, F. "Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B." Tumor Biology 37.1 (2016): 685-698. Link to SFX for this item
6. Kucharova, B. "Potentiation of hypericin-mediated photodynamic therapy cytotoxicity by MK-886: Focus on ABC transporters, GDF-15 and redox status." Photodiagnosis and photodynamic therapy 12.3 (2015): 490-503. Link to SFX for this item
7. Yen, W. "Abstract 3725: Anti-DLL4 (demcizumab) inhibits tumor growth and reduces cancer stem cell frequency in patient-derived ovarian cancer xenografts." Cancer research 2013. 3725-3725. Link to SFX for this item
8. Bankert, Richard B. "Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis." PLoS ONE 6.9 (2011): 9-9. Link to Full Text for this item Link to SFX for this item
9. Rodeck, Ulrich P. "Differential regulation of p53 function by the N-terminal ΔNp53 and Δ113p53 isoforms in zebrafish embryos." BMC developmental biology 10 (2010): 102-102. Link to Full Text for this item Link to SFX for this item
10. di Clemente, N. "Processing of Anti-Mullerian Hormone Regulates Receptor Activation by a Mechanism Distinct from TGF-{beta}." Molecular endocrinology 24.11 (2010): 2193-206. Link to SFX for this item
11. Monk, Bradley J. "Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer." Journal of clinical oncology 28.19 (2010): 3107-3114. Link to SFX for this item
12. Hilovska, L. "Downregulation of BCRP and anti-apoptotic proteins by proadifen (SKF-525A) is responsible for the enhanced mitoxantrone accumulation and toxicity in mitoxantrone-resistant human promyelocytic leukemia cells." International journal of oncology 47.4 (2015): 1572-1584. Link to SFX for this item
13. Rendosova, M. "New silver complexes with bioactive glycine and nicotinamide molecules – Characterization, DNA binding, antimicrobial and anticancer evaluation." Journal of inorganic biochemistry 168 (2017): 1-12. Link to SFX for this item
14. Janockova, J. "Inhibition of DNA topoisomerases I and II and growth inhibition of HL-60 cells by novel acridine-based compounds." European journal of pharmaceutical sciences 76 (2015): 192-202. Link to SFX for this item
15. Underwood, Natasha L. "Human papillomavirus vaccination among adolescents in Georgia." Human vaccines & immunotherapeutics 27.7 (2015): 1703-1708. Link to Full Text for this item Link to SFX for this item
16. Sèdes, L. "Anti-Müllerian hormone recruits BMPR-IA in immature granulosa cells." PLoS ONE 8.11 (2013). Link to Full Text for this item Link to SFX for this item
17. Silden, E. "Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53(null) Cell Lines." PLoS ONE 8.2 (2013). Link to Full Text for this item Link to SFX for this item
18. Milliken, D. "Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites." Clinical cancer research 8.4 (2002): 1108-1114. Link to SFX for this item
19. Zerbini, Luiz F. "Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy." PLoS ONE 6.9 (2011). Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced